Literature DB >> 21274681

MRI in rodent models of brain disorders.

Aleksandar Denic1, Slobodan I Macura, Prasanna Mishra, Jeffrey D Gamez, Moses Rodriguez, Istvan Pirko.   

Abstract

Magnetic resonance imaging (MRI) is a well-established tool in clinical practice and research on human neurological disorders. Translational MRI research utilizing rodent models of central nervous system (CNS) diseases is becoming popular with the increased availability of dedicated small animal MRI systems. Projects utilizing this technology typically fall into one of two categories: 1) true "pre-clinical" studies involving the use of MRI as a noninvasive disease monitoring tool which serves as a biomarker for selected aspects of the disease and 2) studies investigating the pathomechanism of known human MRI findings in CNS disease models. Most small animal MRI systems operate at 4.7-11.7 Tesla field strengths. Although the higher field strength clearly results in a higher signal-to-noise ratio, which enables higher resolution acquisition, a variety of artifacts and limitations related to the specific absorption rate represent significant challenges in these experiments. In addition to standard T1-, T2-, and T2*-weighted MRI methods, all of the currently available advanced MRI techniques have been utilized in experimental animals, including diffusion, perfusion, and susceptibility weighted imaging, functional magnetic resonance imaging, chemical shift imaging, heteronuclear imaging, and (1)H or (31)P MR spectroscopy. Selected MRI techniques are also exclusively utilized in experimental research, including manganese-enhanced MRI, and cell-specific/molecular imaging techniques utilizing negative contrast materials. In this review, we describe technical and practical aspects of small animal MRI and provide examples of different MRI techniques in anatomical imaging and tract tracing as well as several models of neurological disorders, including inflammatory, neurodegenerative, vascular, and traumatic brain and spinal cord injury models, and neoplastic diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21274681      PMCID: PMC3075741          DOI: 10.1007/s13311-010-0002-4

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  147 in total

1.  A novel method for simultaneous anterograde and retrograde labeling of spinal cord motor tracts in the same animal.

Authors:  E C Tsai; R L van Bendegem; S W Hwang; C H Tator
Journal:  J Histochem Cytochem       Date:  2001-09       Impact factor: 2.479

2.  MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE.

Authors:  M Rausch; P Hiestand; D Baumann; C Cannet; M Rudin
Journal:  Magn Reson Med       Date:  2003-08       Impact factor: 4.668

Review 3.  Imaging iron stores in the brain using magnetic resonance imaging.

Authors:  E Mark Haacke; Norman Y C Cheng; Michael J House; Qiang Liu; Jaladhar Neelavalli; Robert J Ogg; Asadullah Khan; Muhammad Ayaz; Wolff Kirsch; Andre Obenaus
Journal:  Magn Reson Imaging       Date:  2005-01       Impact factor: 2.546

Review 4.  A potential role for CD8+ T-cells as regulators of CNS vascular permeability.

Authors:  Georgette L Suidan; Istvan Pirko; Aaron J Johnson
Journal:  Neurol Res       Date:  2006-04       Impact factor: 2.448

5.  Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging.

Authors:  R Weissleder; P F Hahn; D D Stark; G Elizondo; S Saini; L E Todd; J Wittenberg; J T Ferrucci
Journal:  Radiology       Date:  1988-11       Impact factor: 11.105

6.  Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function.

Authors:  Y J Lin; A P Koretsky
Journal:  Magn Reson Med       Date:  1997-09       Impact factor: 4.668

7.  Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.

Authors:  Joseph F Poduslo; Geoffry L Curran; Jane A Peterson; Daniel J McCormick; Abdul H Fauq; Murad A Khan; Thomas M Wengenack
Journal:  Biochemistry       Date:  2004-05-25       Impact factor: 3.162

8.  Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging.

Authors:  Jiangyang Zhang; Paul Yarowsky; Marcia N Gordon; Giovanni Di Carlo; Sanjay Munireddy; Peter C M van Zijl; Susumu Mori
Journal:  Magn Reson Med       Date:  2004-03       Impact factor: 4.668

9.  MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain.

Authors:  Jeff W M Bulte; Tamir Ben-Hur; Bradley R Miller; Rachel Mizrachi-Kol; Ophira Einstein; Etti Reinhartz; Holly A Zywicke; Trevor Douglas; Joseph A Frank
Journal:  Magn Reson Med       Date:  2003-07       Impact factor: 4.668

10.  Multiple sclerosis: pathogenesis and MR imaging features of T1 hypointensities in a [corrected] murine model.

Authors:  Istvan Pirko; Tifany K Nolan; Scott K Holland; Aaron J Johnson
Journal:  Radiology       Date:  2008-03       Impact factor: 11.105

View more
  26 in total

1.  CD8 T cell-initiated blood-brain barrier disruption is independent of neutrophil support.

Authors:  Holly L Johnson; Yi Chen; Fang Jin; Lisa M Hanson; Jeffrey D Gamez; Istvan Pirko; Aaron J Johnson
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

2.  Automatic Brain Extraction for Rodent MRI Images.

Authors:  Yikang Liu; Hayreddin Said Unsal; Yi Tao; Nanyin Zhang
Journal:  Neuroinformatics       Date:  2020-06

Review 3.  Using cross-species comparisons and a neurobiological framework to understand early social deprivation effects on behavioral development.

Authors:  Zoë H Brett; Kathryn L Humphreys; Alison S Fleming; Gary W Kraemer; Stacy S Drury
Journal:  Dev Psychopathol       Date:  2015-05

Review 4.  Standards for preclinical research and publications in developmental anaesthetic neurotoxicity: expert opinion statement from the SmartTots preclinical working group.

Authors:  Gregory A Chinn; Matthew L Pearn; Laszlo Vutskits; Cyrus D Mintz; Andreas W Loepke; Jennifer J Lee; Jerri Chen; Zeljko J Bosnjak; Ansgar M Brambrink; Vesna Jevtovic-Todorovic; Lena S Sun; Jeffrey W Sall
Journal:  Br J Anaesth       Date:  2020-03-04       Impact factor: 9.166

5.  Potassium channel complex autoimmunity induced by inhaled brain tissue aerosol.

Authors:  Jeffrey W Meeusen; Christopher J Klein; Istvan Pirko; Keegan E Haselkorn; Thomas J Kryzer; Sean J Pittock; Daniel H Lachance; P James Dyck; Vanda A Lennon
Journal:  Ann Neurol       Date:  2012-03       Impact factor: 10.422

Review 6.  Mouse models of gene-environment interactions in schizophrenia.

Authors:  Geetha Kannan; Akira Sawa; Mikhail V Pletnikov
Journal:  Neurobiol Dis       Date:  2013-06-05       Impact factor: 5.996

7.  Maternal choline supplementation in a sheep model of first trimester binge alcohol fails to protect against brain volume reductions in peripubertal lambs.

Authors:  Sharla M Birch; Mark W Lenox; Joe N Kornegay; Beatriz Paniagua; Martin A Styner; Charles R Goodlett; Tim A Cudd; Shannon E Washburn
Journal:  Alcohol       Date:  2016-08-04       Impact factor: 2.405

Review 8.  Cell tracking technologies for acute ischemic brain injury.

Authors:  Felicity N E Gavins; Helen K Smith
Journal:  J Cereb Blood Flow Metab       Date:  2015-05-13       Impact factor: 6.200

Review 9.  Non-Invasive Evaluation of Cerebral Microvasculature Using Pre-Clinical MRI: Principles, Advantages and Limitations.

Authors:  Bram Callewaert; Elizabeth A V Jones; Uwe Himmelreich; Willy Gsell
Journal:  Diagnostics (Basel)       Date:  2021-05-21

10.  Imaging of VSOP labeled stem cells in agarose phantoms with susceptibility weighted and T2* weighted MR Imaging at 3T: determination of the detection limit.

Authors:  Donald Lobsien; Antje Y Dreyer; Albrecht Stroh; Johannes Boltze; Karl-Titus Hoffmann
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.